Steven L. Stice, PhD: "Amplification of neural progenitor cells for FDA safety standards?"

About this talk

"Amplification of neural progenitor cells derived from embryonic stem cells solve problems of cell production and FDA safety standards?"
Steven L. Stice, Professor, GRA Eminent Scholar and Director of the Regenerative Bioscience Center at University of Georgia and CSO, Aruna Biomedical Inc.

About Steven L. Stice, PhD

Currently, Dr. Stice's research focuses on developing innovative stem cell technologies for curing diseases.  He co-founded CytoGenesis, Inc., which was later purchased by BresaGen.  Dr. Stice helped BresaGen develop three human embryonic stem cell lines approved for NIH funding. Read full bio

Stem Cell News
> New Technologies
> Stem Cell Politics
> Upcoming events

Workshop Sponsors

The 2009 Workshop was sponsored by

Irv & Diane Naylor

and

MILLIPORE

Site Statistics

Content View Hits : 51787

Share This Video

Goal

The goal of the 2008 Spinal Workshop was to bring together the three key areas: Neurosurgery, Neurology, and Basic Science to identify the remaining barriers to cure. By the end of this one-day workshop, the group had produced a list of the current barriers. The report from this workship serves as a guideline for seeking the resources necessary to solve the problems identified.

Format

This workshop was not designed to be a general exchange of ideas, but rather a clinical / basic science interchange to solve specific, targeted problems. During the morning session, the workshop’s faculty presented each of the major areas of research. During the afternoon session, the faculty focused on summarizing and targeting the current barriers in each area. At the end of the day, all these presentations will culminate in a list of these barriers and discussion of next steps for moving the research forward.